Citation Impact
Citing Papers
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
2015 Standout
Differential diagnosis of suspected multiple sclerosis: a consensus approach
2008
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Attention gated networks: Learning to leverage salient regions in medical images
2019 Standout
Artificial intelligence in healthcare: past, present and future
2017 Standout
Comprehensive Examination of Therapies for Pain in Parkinson’s Disease: A Systematic Review and Meta-Analysis
2018
Restless legs syndrome/Willis–Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria – history, rationale, description, and significance
2014 Standout
Willis-Ekbom Disease Foundation Revised Consensus Statement on the Management of Restless Legs Syndrome
2013
Efficient multi-scale 3D CNN with fully connected CRF for accurate brain lesion segmentation
2016 Standout
Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review
2019
Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis
2014
Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis
2008 Standout
Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis
2008
International Parkinson and movement disorder society evidence‐based medicine review: Update on treatments for the motor symptoms of Parkinson's disease
2018
Parkinson's disease
2021 Standout
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
2010 Standout
A three-year, multi-parametric MRI study in patients at presentation with CIS
2008
The spectrum of neuromyelitis optica
2007 Standout
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
2010 Standout
Differences in retinal nerve fiber layer atrophy between multiple sclerosis subtypes
2009
Evidence for a two-stage disability progression in multiple sclerosis
2010
Pathological roles of MAPK signaling pathways in human diseases
2010 Standout
Will Rogers phenomenon in multiple sclerosis
2008
Stem Cell Therapies in Clinical Trials: Progress and Challenges
2015 Standout
Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases
2009
The Clinical Epidemiology of Multiple Sclerosis
2008
Activation and regulation of the inflammasomes
2013 Standout
The radiologically isolated syndrome: take action when the unexpected is uncovered?
2010
Type I interferons in infectious disease
2015 Standout
Natural History of Multiple Sclerosis Symptoms
2013 Standout
Difference in Disease Burden and Activity in Pediatric Patients on Brain Magnetic Resonance Imaging at Time of Multiple Sclerosis Onset vs Adults
2009
The cost burden of multiple sclerosis in the United States: a systematic review of the literature
2013
Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
2018 Standout
Multiple sclerosis
2008 Standout
Pharmacological Approaches to the Management of Secondary Progressive Multiple Sclerosis
2017
The epidemiology of multiple sclerosis
2016
A substantial and confusing variation exists in handling of baseline covariates in randomized controlled trials: a review of trials published in leading medical journals
2009
Immunopathology of multiple sclerosis
2015 Standout
A survey on deep learning in medical image analysis
2017 Standout
Automated detection of multiple sclerosis lesions in serial brain MRI
2011
Inflammasomes: mechanism of assembly, regulation and signalling
2016 Standout
Axonal Transection in the Lesions of Multiple Sclerosis
1998 Standout
Why have we failed to achieve neuroprotection in Parkinson's disease?
2009
Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double‐blind placebo‐controlled multicenter trial
2009
An Inflection Point in Gene Discovery Efforts for Neurodegenerative Diseases
2013
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
2011 Standout
A deep learning model integrating FCNNs and CRFs for brain tumor segmentation
2017 Standout
Generalised Dice Overlap as a Deep Learning Loss Function for Highly Unbalanced Segmentations
2017 Standout
Development of a New Patient-Reported Outcome Measure for Breast Surgery: The BREAST-Q
2009 Standout
Non-motor features of Parkinson disease
2017 Standout
New Multiple Sclerosis Phenotypic Classification
2014 Standout
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study
2012
Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations
2007
Deep Learning for Brain MRI Segmentation: State of the Art and Future Directions
2017 Standout
An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis
2011 Standout
The Pathobiology of Vascular Dementia
2013 Standout
MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study
2007
Long-term Follow-up of Acute Partial Transverse Myelitis
2012
Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity‐score matched samples
2009 Standout
Multiple sclerosis: a complicated picture of autoimmunity
2007
Inflammasomes: mechanism of action, role in disease, and therapeutics
2015 Standout
Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation
2011
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
2005 Standout
Inflammasomes in health and disease
2012 StandoutNature
Succinate Dehydrogenase Supports Metabolic Repurposing of Mitochondria to Drive Inflammatory Macrophages
2016 Standout
Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis
2008
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Treatment effects of immunomodulatory therapies at different stages of multiple sclerosis in short-term trials
2010
Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis
2013
Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease
2009
Intracortical lesions
2010
Diagnosis and Treatment of Parkinson Disease
2020 Standout
Multiple Sclerosis
2018 Standout
Long‐term safety and efficacy of levodopa‐carbidopa intestinal gel in advanced Parkinson's disease
2018
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
IMMUNOLOGY OF MULTIPLE SCLEROSIS
2005 Standout
H-DenseUNet: Hybrid Densely Connected UNet for Liver and Tumor Segmentation From CT Volumes
2018 Standout
Artificial intelligence in cancer imaging: Clinical challenges and applications
2019 Standout
Artificial intelligence for precision education in radiology
2019 Standout
Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis
2009
Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients.
2009
Religious Orders Study and Rush Memory and Aging Project
2018 Standout
The rising prevalence and changing age distribution of multiple sclerosis in Manitoba
2010 Standout
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Multiple Sclerosis: Identification of Temporal Changes in Brain Lesions with Computer-Assisted Detection Software
2013
Compliance with McDonald criteria and red flag recognition in a general neurology practice in Ireland
2010
Basic and escalating immunomodulatory treatments in multiple sclerosis: Current therapeutic recommendations
2008
Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?
2007
Works of Lars Bauer being referenced
Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson’s disease
2016
Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study
2007
Subtraction MR Images in a Multiple Sclerosis Multicenter Clinical Trial Setting
2008
Safety and efficacy of rotigotine transdermal patch in patients with restless legs syndrome: apost-hocanalysis of patients taking 1 – 3 mg/24 h for up to 5 years
2012
Magnetic Resonance Imaging Effects of Interferon Beta-1b in the BENEFIT Study
2007
Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial
2009
Lack of Association between Antimyelin Antibodies and Progression to Multiple Sclerosis
2007
Evaluation of rotigotine transdermal patch for the treatment of depressive symptoms in patients with Parkinson’s disease
2016
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes
2006
Effects of rotigotine transdermal patch in patients with Parkinson's disease presenting with non‐motor symptoms – results of a double‐blind, randomized, placebo‐controlled trial
2015
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes
2006
A Randomized Controlled Exploratory Pilot Study to Evaluate the Effect of Rotigotine Transdermal Patch on Parkinson's Disease-Associated Chronic Pain
2015
Impulse control disorder related behaviours during long‐term rotigotine treatment: a post hoc analysis
2016
Discrepancies in the interpretation of clinical symptoms and signs in the diagnosis of multiple sclerosis. A proposal for standardization
2005